Condition
Recurrent Bacterial Vaginosis (BV)
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Vaginal Microbiome Transplantation Vmt
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Phase 2 (2)
Trial Status
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Vaginal Microbiome Transplantation Vmt1
- Metronidazole1
- 1 Spl7013 Gel1
- 3 Spl7013 Gel1
- Sterile Saline Solution1
Active Sponsors
- Douglas Kwon1
- Starpharma Pty Ltd1
- Bill and Melinda Gates Foundation1
- Massachusetts General Hospital1
Top Investigators
Ragon Institute of MGB, MIT, and Harvard
Starpharma Pty Ltd
Ragon Institute of MGB, MIT, and Harvard
Massachusetts General Hospital